Cargando…
A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris
INTRODUCTION: Rituximab is slowly getting recognized as a promising steroid-sparing agent in the treatment of moderate to severe cases of pemphigus vulgaris (PV). We evaluated and compared the effectiveness, safety, and cost of therapy of rituximab versus dexamethasone cyclophosphamide pulse (DCP) i...
Autores principales: | Das, Sudip, Agarwal, Komal, Singh, Sonal, Halder, Deepika, Sinha, Sujata, De, Abhishek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208287/ https://www.ncbi.nlm.nih.gov/pubmed/34188295 http://dx.doi.org/10.4103/ijd.IJD_306_20 |
Ejemplares similares
-
Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study()
por: Fontenelle, Ludmilla Figueiredo, et al.
Publicado: (2023) -
Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012) -
Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
por: Das, Sudip, et al.
Publicado: (2011) -
Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015) -
Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)